Co-development Partnering Terms & Agreements in Pharma, Biotech and Diagnostics: 2014 to 2019

/EIN News/ -- Dublin, Feb. 03, 2020 (GLOBE NEWSWIRE) -- The "Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014 to 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies.

This report provides details of the latest Co-development agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of Co-development agreements from 2014 to 2019.

There is an increasing willingness for parties to enter co-development deals; such deals enable both parties to benefit from the upside of a big product win, whereas traditional licensing deals forfeit upside for near term upfront, milestone and royalty payments.

Co-development partnering allow the parties to securitize value and reduce risk, but keep a part of the potential upside should the product reach the market. Event if the licensor does not commercialize the project they can either sell those rights to the licensee partner or another partner for an amount higher than would have been achieved at an earlier stage licensing deal.

There are mainly two forms of co-development deals; Either the parties agree on a certain division of ownership, or decide that one party gets the rights to commercialise the drug in a certain geographical area, and the other side gets the other geographical area rights. Typically, the ownership division applies when it is likely that the project will be licensed at a later point in time. The geographical split usually applies when the two companies are determined to commercialise the drug themselves.

Another reason for co-development deals is the joint origin of a project. Drug development projects often require various scientific and technological novelties that stem from different companies. If both companies contributed to the origination of the project, then both have from the beginning a stake in the project.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of Co-development deals announced since 2014 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual Co-development contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2019 includes:

• Trends in co-development dealmaking in the biopharma industry since 2014
• Analysis of co-development deal structure
• Case studies of real-life co-development deals
• Comprehensive listing of co-development deals since 2014
• Access to co-development contract documents
• Key financial bnchmarks for headline, upfront, milestone and royalty rates
• The leading co-development deals by value since 2014
• Most active co-development dealmakers since 2014
• The leading co-development partnering resources

Available deals and contracts are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type

Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How do milestone align with clinical stage development phases?
• How aresalesand payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Co-development dealmaking
2.1. Introduction
2.2. Definition of co-development deals
2.3. Success factors for co-development deals
2.4. When co-development can be useful
2.5. Attributes of co-development deals
2.6. Aligning partners to make the co-development work
2.7. Trends in Co-development deals since 2014
2.7.1. Co-development dealmaking by year, 2014 to 2019
2.7.2. Co-development dealmaking by phase of development, 2014 to 2019
2.7.3. Co-development dealmaking by industry sector, 2014 to 2019
2.7.4. Co-development dealmaking by therapy area, 2014 to 2019
2.7.5. Co-development dealmaking by technology type, 2014 to 2019
2.7.6. Co-development dealmaking by most active company, 2014 to 2019
2.8. Option to co-develop
2.9. The future of co-development deals

Chapter 3 - Overview of Co-development deal structure
3.1. Introduction
3.2. Pure versus multi-component co-development deals
3.3. Pure co-development agreement structure
3.3.1. Example co-development agreements
3.3.1.a. Case study 1: Ambrx - Zhejiang Medicine
3.3.1.b. Case study 2: UniQure - Chiesi

Chapter 4 - Leading Co-development deals
4.1. Introduction
4.2. Top Co-development deals by value

Chapter 5 - Top 25 most active Co-development dealmakers
5.1. Introduction
5.2. Top 25 most active Co-development dealmakers

Chapter 6 - Co-development deal term financials
6.1. Introduction
6.2. Co-development partnering headline values
6.3. Co-development deal upfront payments
6.4. Co-development deal milestone payments
6.5. Co-development royalty rates

Chapter 7 - Co-development deals including contracts directory
7.1. Introduction
7.2. Co-development deals with contracts 2014 to 2019

Appendices
Appendix 1 - Co-development dealmaking by companies A-Z
Appendix 2 - Co-development dealmaking by industry sector
Appendix 3 - Co-development dealmaking by stage of development
Appendix 4 - Co-development dealmaking by therapy area
Appendix 5 - Co-development dealmaking by technology

Companies Mentioned

• 1ST Biotherapeutics
• 3B Pharmaceuticals
• 3D-Micromac
• 3DMed
• 3D Systems
• 10X Genomics
• A*STAR Agency for Science
• Technology and Research
• A*STAR Institute of Microelectronics (IME)
• Abbvie
• AbCellera
• ABL Bio
• Abpro
• Academy of Military Medical Sciences (China)
• Accord Healthcare
• AccuGenomics
• ACEA Biosciences
• AC Immune
• Acoustic MedSystems
• Adaptimmune
• Aduro BioTech
• Advaxis
• Adventus Ventures
• Aerolase
• Affibody
• Affimed Therapeutics
• Agena Bioscience
• Agendia
• Agilent Technologies
• AiLife Diagnostics
• Ajinomoto
• Albany Molecular Research
• Alexion Pharmaceuticals
• Allegheny Technologies
• Allele Biotechnology and Pharmaceuticals
• Alligator Bioscience
• Allotex
• Alnylam Pharmaceuticals
• Alphaeon
• Alphamab
• Alteogen
• Altor BioScience
• Altos Group
• Alzheimer's Drug Discovery Foundation
• Ambrx
• Amedica
• Amerigen Pharmaceuticals
• Amgen
• AnaptysBio
• AnGes MG
• Angionetics
• Annoroad
• Ansell
• Anteo Diagnostics
• Anthem
• AntiOp
• AOP Orphan Pharmaceuticals
• Apobiologix
• Aptar Pharma
• Aptevo Therapeutics
• Aquestive Therapeutics
• Aranda Pharma
• ARaymondlife
• Arbele
• Arbutus
• Arcturus Therapeutics
• Areva Med
• Ariad Pharmaceuticals
• Arno Therapeutics
• Artes Biotechnology
• Asahi Intecc
• Ascenion
• Ascensia Diabetes Care
• Astellas Pharma
• AstraZeneca
• AutoGenomics
• Avactis Biosciences
• Avalanche Biotechnologies
• Avalon GloboCare
• Aviragen Therapeutics
• Axela
• AXIM Biotechnologies
• Banyan Biomarkers
• BASF
• Bayer
• Bayer Healthcare
• Baylor College of Medicine
• BD Biosciences
• BeiGene
• Beijing Sun-Novo Pharmaceutical Research
• Berry Genomics
• Betta Pharmaceuticals
• BGI Americas
• Biedermann Motech
• Bio-Rad Laboratories
• Bio-Techne
• BioAtla
• Biocept
• Biocon
• Biodextris
• BioGemex
• Biogen
• BioInvent
• BioLabs
• BioLegend
• BiolineRX
• BIOMEDX Group
• bioMerieux
• BioNano Genomics
• Bionpharma
• BioNTech
• BioPontis Alliance
• BioSerenity
• Biostar Pharmaceuticals
• BioSun Pharmed
• Bioventus
• Bird Foundation
• Blake Insomnia Therapeutics
• Bluebird Bio
• Boehringer Ingelheim
• BoneSupport
• Boreal Genomics
• Boston Scientific
• Breathe ECig
• Bridge Biotherapeutics
• Brigham and Women's Hospital
• Bristol-Myers Squibb
• Broad Institute
• Bruker
• Bruker Energy & Supercon Technologies (BEST)
• Burnet Institute
• c-LEcta
• Cactus Semiconductor
• California Institute for Biomedical Research
• Cambrooke Therapeutics
• Cancer Prevention Pharmaceuticals
• Cancer Research Technology
• CannScience Innovations
• Capsule Tech
• Cardiovascular Systems
• CBT Pharmaceuticals
• CEA-Leti
• Celgene
• Cellastra
• Cellectis
• Cellgen Diagnostics
• Celltrion
• Cellular Biomedicine
• Celon Pharma
• Censa Pharmaceuticals
• Center for Connected Health
• Center for Sensorimotor Neural Engineering
• Central Institute for Experimental Animals
• Centre for Drug Research and Development (CDRD)
• Centre for Imaging Technology Commercialization
• Cerenis Therapeutics
• Cerulean Pharma
• Changzhou Le Sun Pharmaceuticals
• ChemDiv
• Chi-Med
• China National Biotech Group (CNBG)
• ChromaDex
• ChroMedX
• Cipla
• Ciron Drugs & Pharmaceuticals
• Cleveland Clinic
• Clevexel Pharma
• Clinical Study Support
• Coeptis Pharmaceuticals
• College of Life Science of Northwest University
• Complement Pharma
• Conductive Technologies
• Confluence Pharmaceuticals
• Conkwest
• Context Therapeutics
• CRISPR Therapeutics
• Crystal Bioscience
• CrystalGenomics
• CSPC Pharmaceutical Group
• CureVac
• CutisPharma
• Cygnus
• Cytokinetics
• CytomX Therapeutics
• Daewoong Pharmaceutical
• Daiichi Sankyo
• Dainippon Sumitomo Pharma
• Dako
• Dalton Pharma Services
• Dance Biopharm
• DaRui Biotech
• Decision Diagnostics
• Definiens
• Department of Defense
• Department of Health and Human Services
• DePuy
• Dexcel Pharma
• Dilafor
• Dilaforette
• DNAnexus
• Dr. Reddy's Laboratories
• Dynavax Technologies
• Ecole Polytechnique Federale de Lausanne
• EdeniQ
• Eisai
• Elekta
• Elektrofi
• ElevateBio
• Eli Lilly
• Elite Pharmaceuticals
• Elpis Biomed
• Em-Tec
• Emergent BioSolutions
• Enigma Biomedical
• Entasis Therapeutics
• Enterome Bioscience
• Ergomed
• Essex Bio-Technology
• Evercyte
• Evidera
• Evolva
• Evosep
• Evotec
• Evvivax
• Excelra
• Exosome
• Fabric Genomics
• Fate Therapeutics
• Ferrer International
• Firebrand Therapeutics
• FlowJo
• Fluxion Biosciences
• G2 Speech
• GB Sciences
• Gedeon Richter
• GE Healthcare
• Genea Biomedx
• Genentech
• Generex Biotechnology
• Genethon
• Genmab
• Genomas
• Genome Institute of Singapore
• Genomic Testing Cooperative
• Genomoncology
• Genoptix
• Genzyme
• Georgia State University Research Foundation (GSURF)
• Gilead Sciences
• GlaxoSmithKline
• Global Antibiotic Research and Development Partnership
• Global Bio-chem Technology Group
• GMSbiotech
• Government of Canada
• Greiner Bio-One
• GTEC Holdings
• Guilin Pharmaceutical
• H.M. Pharma Consultancy
• H3 Biomedicine
• Hainan Sihuan Pharmaceutical
• HalioDx
• Hangzhou Joinstar Biomedical Technology
• Hanmi Pharmaceutical
• Harbour Antibodies
• Harvard University
• HCD Research
• HD Biosciences
• HealthCore
• Heartflow
• HEC Pharm
• Hereditary Neuropathy Foundation
• Horizon Discovery
• Hoth Therapeutics
• HTC ChemRar
• I-mab
• IBA
• IBC Generium
• iBio
• IBM Watson Health
• Icagen
• Idorsia
• Illumina
• ImmBio
• Immune Design
• Immunocore
• Impression Healthcare
• Imricor Medical Systems
• Incyte
• InDi Molecular
• Infinity Pharmaceuticals
• Innate Pharma
• inno-train Diagnostik
• Innovent Biologics
• Inova Genomics Laboratory
• Inovio Pharmaceuticals
• Insitro
• InstantLabs
• Institute for Research in Immunology and Cancer - Commercialization of Research
• Institute of Cancer Research
• Institut Gustave Roussy
• Integrated Cannabis Company
• IntelGenx
• Intravacc
• Intuitive Surgical
• InventisBio
• inviCRO
• Ionis Pharmaceuticals
• iPharma
• Ipsen
• ISIS Innovation
• Isomerase Therapeutics
• Jabez Pharma
• Janssen Biotech
• Janssen Pharmaceuticals
• Janssen Pharmaceutica NV
• JCR Pharmaceuticals
• Jeffrey Modell Foundation
• JETA Molecular
• Jiangsu NHWA Pharmaceutical
• Johns Hopkins University
• Johnson & Johnson Innovation
• Juno Therapeutics
• JustRight Surgical
• Kaken Pharmaceutical
• Kane Biotech
• Klaria
• Kleo Pharmaceuticals
• Lannett
• Lead Discovery Center
• Lee's Pharmaceutical
• Leica Biosystems
• Leon-nanodrugs
• LEO Pharma
• Les Laboratoires Servier
• Leukemia & Lymphoma Society
• LifeLink Foundation
• LifeLiver
• LifeQ
• LineaRx
• LogicNets
• Loreal
• Louisiana State University
• Loxo Oncology
• Lupin Limited
• Luye Pharma Group
• Macrogen
• Mallinckrodt Pharmaceuticals
• Marina Biotech
• Marshall Institute for Interdisciplinary Research
• Marshall University
• MaRS Innovation
• Masimo
• Massachusetts General Hospital
• Max-Delbruck Center for Molecular Medicine
• Mayo Clinic
• Mazor Robotics
• McCall MacBain Foundation
• MD Anderson Cancer Center
• MedImmune
• Medtronic
• Melinta Therapeutics
• Menarini
• Mercachem
• Merck and Co
• Merck KGaA
• Merck Serono
• Meridian Laboratories
• Mersana Therapeutics
• Merus
• Merz
• MetP Pharma
• Mikrogen
• Millennium
• Minerva Neurosciences
• Mirati Therapeutics
• MiRTLE Medical
• Mission Health
• Moderna Therapeutics
• Molecular Targeting Technologies
• Molecular Templates
• Molnlycke Health Care
• Mologen
• Monash University
• MorphoSys
• MRI Interventions
• Mundo Sano
• Mylan Pharmaceuticals
• MyLife Technologies
• Nanion
• Nanjing King-friend Biochemical Pharmaceutical
• NanoString Technologies
• NantKwest
• NantPharma
• National Cancer Institute
• National Healthcare Services (NHS)
• National Health Research Institutes
• National Immunobiological Company
• National Institutes of Health
• Ncardia
• Nektar Therapeutics
• Neptune Technologies & Bioressources
• NeuClone
• Neuraly
• Neuro France Implants
• NeuroVive Pharmaceutical
• Newsoara Biopharma
• NGM Biopharmaceuticals
• Ningbo Menovo Pharmaceutical
• Nipro Corporation
• Noramco
• Novartis
• NovImmune
• Novogene
• NTT Medical Center Tokyo
• Nuclea Biotechnologies
• Nuevolution
• Numab
• Nurix
• NutriQuest
• NuVasive
• Oncologie
• One BioMed
• OnFace
• Ono Pharmaceutical
• OPKO Health
• Opocrin S.p.A
• Optum
• Oregon Health Sciences University
• Orgenesis
• Orion
• Orthocell
• OSE Immunotherapeutics
• Otsuka
• Oxford BioMedica
• Pacific Biosciences
• Pairnomix
• Palatin Technologies
• Pall Corporation
• Par Pharmaceutical
• PathGroup
• PDS Biotechnology
• Pep Therapy
• PeptiDream
• Perlara
• Personal Genome Diagnostics
• Pfizer
• PharmaCyte Biotech
• Pharma Tech Solutions
• Phillips-Medisize
• PhosImmune
• PhysIOL
• Pieris
• Pierre Fabre
• Planet Wheeler Foundation
• Premier Inc
• PreventionGenetics
• Procter & Gamble
• Profound Medical
• Promethera Biosciences
• Prometic Life Sciences
• Promore Pharma
• Propeller Health
• Protagen
• Protea Biosciences
• Protein Sciences
• Provention Bio
• Pulmatrix
• Purdue Pharma
• Pure MHC
• Pure Protein
• Purolite
• Qiagen
• Qilu Pharmaceutical
• Qualcomm
• Quark Pharmaceuticals
• Radiomedix
• Rainbow Medical
• RainDance Technologies
• Rambam Medical Center
• ReadSense Genomic Center
• Recipharm
• Reckitt Benckiser
• Redlen Technologies
• Regeneron Pharmaceuticals
• Rennovia
• Replicel Life Sciences
• Response Biomedical
• Retrophin
• RightEye
• Roche
• Roivant Sciences
• RoosterBio
• Rosetta Genomics
• Royal Philips Electronics
• Sajo Consulting
• Salus Pharma
• SanBio
• Sanofi
• Sanofi-Pasteur
• Santen Pharmaceutical
• Sarah Cannon Research Institute
• Sarepta Therapeutics
• Sartorius Stedim Biotech
• SBRI Healthcare
• Scandinavian Health
• Scienion
• Sciex
• ScinoPharm Taiwan
• SCM Pharma
• Scottish Enterprise
• Seattle Genetics
• Secarna Pharmaceuticals
• Seegene
• Seipasa
• Selvita
• Semtech
• SENSANALYSIS
• Sentieon
• Seracare Life Sciences
• Serum Institute of India
• Shaanxi Research Institution of Chinese Traditional Medicines
• Shandong Luoxin Pharma
• Shanxi Yabao Pharmaceutical Distribution
• Siemens Healthcare
• Siemens Healthineers
• Sigma-Aldrich
• Simcere Pharmaceuticals
• Sinergium Biotech
• Singulex
• Sirenas
• SK Chemicals
• SkylineDX
• Smartwise
• Soitec
• Sonova
• Sorrento Therapeutics
• Spineguard
• STADA Arzneimittel
• Starpharma
• StemoniX
• Stockton Group
• Stora Enso
• Strand Life Sciences
• Striiv
• SunGen
• Sunnybrook Health Sciences Centre
• Sunny Pharmtech
• Swedish Bactiguard
• Swift Biosciences
• Synergetics
• Synpromics
• Synthonics
• TaiwanJ Pharmaceuticals
• Takeda Pharmaceutical
• Takis
• Tango Therapeutics
• Tarrex Biopharma
• Tauriga Sciences
• Taxus Cardium Pharmaceuticals
• TC BioPharm
• Tecan
• Teijin
• Tesaro
• Tetra Bio-Pharma
• Texas A&M University
• TG Therapeutics
• Theravance
• Therawis Diagnostics
• Tianjin CanSino Biotechnology
• Tillotts Pharma
• Tissue Analytics
• Tobii Technology
• TOMA Biosciences
• Torrey Pines Investment
• Transgene
• Transgenomic
• Translational Software
• Transplant Genomics
• Treeway
• Treventis
• TrovaGene
• Trovita Health Science
• Ubic
• UbiQ
• UCB
• UGISense
• Ultivue
• Ultragenyx Pharmaceuticals
• Uni-Bio Science
• UniQure
• United Therapeutics
• University Hospital of Leuven
• University of Guelph
• University of Montreal
• University of North Texas
• University of Sydney
• Vaccitech
• Valent Biosciences
• Validogen
• Valneva
• Vanderbilt-Ingram Cancer Center
• Vasomune Therapeutics
• Vect-Horus
• VenatoRx
• Ventana Medical Systems
• Vertex Pharmaceuticals
• Vical
• Vici Health Sciences
• Vifor-Fresenius Medical Care Renal Pharma Ltd
• Vinnova
• Vir Biotechnology
• Visualant
• Vium
• WAVE Life Sciences
• Weill Cornell Medical College
• Wellcome Trust
• Willow Biosciences
• Worthington Biochemical Corporation
• WuXi Biologics
• X4 Pharmaceuticals
• Xbrane Bioscience
• Xencor
• XERIS Pharmaceuticals
• Xortx Pharma
• Xylonix
• Yabao Pharmaceutical
• Yale University
• YOFOTO (China) Health Industry
• Yonsei University Severance Hospital
• Yuhan Corporation
• Zavation
• Zhejiang Hisun Pharmaceutical
• Zivo Bioscience
• Zylo Therapeutics

For more information about this report visit https://www.researchandmarkets.com/r/skno9j

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900